T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.58B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Morgan Stanley
MS
|
+$1.15B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 5 |
Apple
AAPL
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$2.82B |
| 3 |
GE Aerospace
GE
|
+$1.93B |
| 4 |
Goldman Sachs
GS
|
+$1.88B |
| 5 |
ServiceNow
NOW
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.25% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.32% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Biogen
BIIB
$31.1B
| $581M | 0.09% |
2,088,356
+691,843
| +50% | +$191M |
|
227
Endava
DAVA
$161M
| $577M | 0.09% |
8,588,111
+333,749
| +4% | +$26.2M |
|
228
Equity Lifestyle Properties
ELS
$12.6B
| $575M | 0.09% |
8,572,482
+837,152
| +11% | +$56.8M |
|
229
Mercado Libre
MELI
$93.3B
| $566M | 0.08% |
429,180
-45,675
| -10% | -$52M |
|
230
Tyson Foods
TSN
$19.8B
| $562M | 0.08% |
9,471,823
+4,669,457
| +97% | +$287M |
|
231
Rayonier
RYN
$6.51B
| $560M | 0.08% |
18,558,318
+355,750
| +2% | +$11M |
|
232
Globant
GLOB
$1.68B
| $559M | 0.08% |
3,406,155
+319,684
| +10% | +$52.2M |
|
233
Norfolk Southern
NSC
$76.1B
| $542M | 0.08% |
2,554,670
-170,151
| -6% | -$39.4M |
|
234
General Motors
GM
$76.2B
| $539M | 0.08% |
14,687,738
+6,548,022
| +80% | +$248M |
|
|
SEM
235
DELISTED
Select Medical
SEM
| $535M | 0.08% |
38,380,887
+114,878
| +0.3% | +$1.69M |
|
236
SLB Ltd
SLB
$77.5B
| $527M | 0.08% |
10,736,684
+7,158,943
| +200% | +$380M |
|
237
Datadog
DDOG
$88.9B
| $522M | 0.08% |
7,181,438
-2,804,372
| -28% | -$206M |
|
238
Broadridge
BR
$19.2B
| $511M | 0.08% |
3,488,037
+96,566
| +3% | +$13.8M |
|
239
Charles River Laboratories
CRL
$13.7B
| $506M | 0.08% |
2,506,293
+653,790
| +35% | +$148M |
|
240
Apollo Global Management
APO
$82.9B
| $493M | 0.07% |
7,808,500
+827,935
| +12% | +$55.4M |
|
241
Centene
CNC
$33B
| $491M | 0.07% |
7,761,031
-15,608,916
| -67% | -$1.11B |
|
242
Bristol-Myers Squibb
BMY
$132B
| $486M | 0.07% |
7,007,819
-389,635
| -5% | -$27.5M |
|
243
RBC Bearings
RBC
$17.5B
| $483M | 0.07% |
2,075,761
-904,735
| -30% | -$208M |
|
244
KE Holdings
BEKE
$18.7B
| $483M | 0.07% |
25,623,503
-494,028
| -2% | -$9.15M |
|
245
State Street
STT
$52B
| $479M | 0.07% |
6,323,218
-1,326,118
| -17% | -$112M |
|
246
Align Technology
ALGN
$12.3B
| $472M | 0.07% |
1,413,060
-220,619
| -14% | -$65.1M |
|
247
RenaissanceRe
RNR
$13.3B
| $472M | 0.07% |
2,355,333
-749,959
| -24% | -$151M |
|
248
Sysco
SYY
$40.4B
| $471M | 0.07% |
6,098,467
-720,598
| -11% | -$55.3M |
|
249
Magna International
MGA
$18.7B
| $469M | 0.07% |
8,759,409
-7,482
| -0.1% | -$433K |
|
250
Teleflex
TFX
$5.79B
| $465M | 0.07% |
1,833,777
+612,019
| +50% | +$148M |
|
Similar funds
T. Rowe Price Associates's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Associates held 3,020 positions worth $668B, up 7.5% from $622B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2023 filing shows 65 new, 1,711 increased, 924 reduced and 98 closed positions. Its largest new stake was Suncor Energy: 6,437,236 shares worth $200M. The largest sale was Alphabet (Google) Class C, an estimated $2.94B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2023 buy was Suncor Energy: 6,437,236 shares worth $200M.
- T. Rowe Price Associates added most to Tesla in Q1 2023, an estimated $1.58B increase.
- T. Rowe Price Associates's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $2.94B.
- T. Rowe Price Associates fully exited Signature Bank in Q1 2023, selling an estimated $360M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $668B portfolio in Q1 2023.
- T. Rowe Price Associates opened 65 new positions and closed 98 in Q1 2023.
- T. Rowe Price Associates's portfolio value rose 7.5% quarter-over-quarter to $668B.
Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.